Our Future
Read Article
Article as MP3
Dear Friends of DAIICHI SANKYO!
Our merger in 2006 brought together two pharmaceutical companies, each with an outstanding history of ‘first-in-class’ and ‘best-in-class’ drug discoveries.
DAIICHI SANKYO’s goal is to satisfy the unmet medical needs of patients and healthcare professionals by continuously developing and providing innovative products and services and be independently competitive in major international markets and maximising its corporate value.
Though we are new in Europe and not yet widely known, count on us, you will hear from us more often through new drug discoveries and new drug launches in the near future.
Based on our combined strengths and powered by our unique heritage and values, we are set to continuously explore for better therapies and new treatments.
We will, thus, provide for a healthier tomorrow for people on all continents!
Yours faithfully
| Reinhard Bauer Chief Executive Officer |
Max Schöner Chief Financial Officer |
